News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead Michael O'Riordan June 20, 2024
Presentation NY Valves 2024 Myosin Inhibitors and Novel Medical Therapies for HCM Presenter: Mark V. Sherrid June 07, 2024
News Conference News ESC Heart Failure 2024 Treatment Gaps Abound in Heart Failure but Can Be Closed, Studies Show Michael O'Riordan May 21, 2024
News Conference News ESC Heart Failure 2024 Delays to Echo and Diagnosis Spell Poor Early Outcomes in Suspected HF Michael O'Riordan May 13, 2024
News Daily News New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise Yael L. Maxwell May 08, 2024
News Daily News SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER Michael O'Riordan May 07, 2024
News Daily News Wearable-Tracked Walking Behavior Hints at Subclinical HF Caitlin E. Cox April 23, 2024
News Daily News In Transporting Donor Hearts, SherpaPak Shows Promise Over Traditional Coolers Yael L. Maxwell April 18, 2024
News Conference News ACC 2024 IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM Caitlin E. Cox April 15, 2024
News Conference News EHRA 2024 Ultralow-Temperature Cryoablation Promising for Monomorphic VT Todd Neale April 12, 2024
Presentation ACC 2024 Efficacy and Safety of Ninerafaxstat, a Novel Cardiac Mitotrope, in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy (Results of IMPROVE-HCM) Presenter: Martin S. Maron April 08, 2024
News Conference News ACC 2024 STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed L.A. McKeown April 06, 2024
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2024 Shelley Wood April 03, 2024
News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024